ArticleEye (London, England)2026

Two-year treatment outcomes in neovascular age-related macular degeneration with type 3 macular neovascularisation.

Yosuke Fukuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.